Study of treatment outcomes for children with aplastic anemia
Part of Blood & lymphatic clinical trials.
This study looks at how children with aplastic anemia (a condition where the bone marrow doesn't make enough blood cells) respond to treatment. It aims to understand what treatments work best and how children do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 1 and 18 years old.
- Diagnosis of acquired (not inherited) aplastic anemia confirmed by bone marrow tests.
- Diagnosed or treated at Assiut University Children's Hospital between August 2023 and August 2026.
- Complete medical records available.
- No history of chemotherapy or radiation for other conditions.
- No other blood or bone marrow diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children with aplastic anemia (a condition where the bone marrow doesn't make enough blood cells) to learn more about how it affects them in the Assiut region. By joining, you help doctors understand the disease better, which may improve care for children like yours.
This trial tests whether giving children with aplastic anemia a transplant using a matched unrelated donor (a bone marrow donor who is not a family member) can help treat their condition. It aims to see if this approach is effective and safe for children who qualify.
This study tests whether adding umbilical cord blood to a stem cell transplant from a half-matched donor can improve outcomes for people with severe aplastic anemia or related bone marrow failure diseases.
This study tests an experimental treatment made from special immune cells designed to help your body fight aplastic anemia. It may be an option if you still need blood transfusions despite standard treatments.
This trial tests a new way of preparing adult patients with hard-to-treat aplastic anemia for a stem cell transplant. It uses a lower-intensity conditioning regimen (TMI) and umbilical cord blood, which may be safer and more effective for patients who have failed other treatments.
This trial tests whether an early bone marrow transplant from a half-matched family member or an unrelated donor can help people with severe aplastic anemia. It aims to restore the body's ability to make healthy blood cells.
Hear when a new Aplastic Anaemia (AA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.